# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA991490 | F | Cytotoxicity against human B-CPAP cells assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
2. | ALA2363752 | F | SANGER: Inhibition of human BCPAP cell growth in a cell viability assay. | Homo sapiens | 98 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | ||
3. | ALA4140599 | F | Antiproliferative activity against human BCPAP cells after 48 hrs by MTT assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
4. | ALA4359525 | F | Cytotoxicity against RET deficient human BCPAP cells supplemented with fresh medium containing compound for every 2 to 3 days measured during compound dosing | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
5. | ALA4709275 | F | Cytotoxicity against human BCPAP cells assessed as reduction in cell viability incubated for 24 hrs by CCK-8 assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
6. | ALA5241185 | F | Antiproliferative activity against human BCPAP cells harboring BRAF V600E mutation assessed as cell growth inhibition at 5 uM by cell counting assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
7. | ALA5262276 | F | Cytotoxicity against human BCPAP cells measured after 8 days | Homo sapiens | 2 | cell-based format | Scientific Literature |